Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

The dermorphin peptide family

P Melchiorri¹, L Negri

¹Institute of Medical Pharmacology, University of Rome, La Sapienza, Italy.

General Pharmacology

|October 1, 1996

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Black Hole Spectroscopy and Tests of General Relativity with GW250114.

Physical review letters·2026

Same author

GW250114: Testing Hawking's Area Law and the Kerr Nature of Black Holes.

Physical review letters·2025

Same author

Bilateral testicular masses and adrenal insufficiency: is congenital adrenal hyperplasia the only possible diagnosis? First two cases of TARTS described in Addison-only X-linked adrenoleukodystrophy and a brief review of literature.

Journal of endocrinological investigation·2020

Same author

Towards quality assessed characterization of nanomaterial: Transfer of validated protocols for size measurement by dynamic light scattering and evaluation of zeta potential by electrophoretic light scattering.

International journal of pharmaceutics·2017

Same author

The prokineticin Bv8 sensitizes cutaneous terminals of female mice to heat.

European journal of pain (London, England)·2016

Same author

PC1, a non-peptide PKR1-preferring antagonist, reduces pain behavior and spinal neuronal sensitization in neuropathic mice.

Pharmacological research·2014

Dermorphins, peptides from frog skin, are potent analgesics with potential for pain relief. These compounds show greater efficacy and fewer side effects than morphine in animal studies.

Area of Science:

Pharmacology
Neuroscience
Peptide Chemistry

Background:

Discovery of dermorphins, selective mu-opioid agonists, from Phyllomedusinae frog skin in 1980.
Expansion of the dermorphin family to seven natural peptides and nearly 30 synthetic analogs over 15 years.

Purpose of the Study:

To investigate the analgesic properties and therapeutic potential of dermorphin peptides.
To compare the efficacy and side effect profiles of dermorphins with morphine.

Main Methods:

Administration of dermorphins to rodents and primates.
Assessment of antinociception and central effects after peripheral administration.
Chronic exposure experiments in rats and mice.

Main Results:

Related Experiment Videos

Dermorphins demonstrate potent analgesic effects in various species, including humans.
Some dermorphins can cross the blood-brain barrier for central pain relief.
Compared to morphine, dermorphins exhibit higher potency and efficacy.
Dermorphins show a reduced likelihood of inducing tolerance, dependence, and opiate side effects.

Conclusions:

Dermorphin peptides represent a promising class of analgesics with a superior therapeutic profile to morphine.
Their ability to cross the blood-brain barrier and reduced side effects warrant further investigation for pain management.